Runda Medical(SH:603108) Shang Hai Zheng Quan Bao·2025-05-22 20:42Core Viewpoint - The company has decided not to exercise the early redemption rights for its convertible bonds, despite meeting the conditions for redemption, to protect investor interests and due to existing financial commitments [2][6]. Group 1: Convertible Bond Redemption - The company's stock has met the condition of having at least 15 trading days with closing prices not lower than 130% of the current conversion price over a 30-day period from April 29, 2025, to May 22, 2025, triggering the redemption clause for the "Run Da Convertible Bonds" [2][5]. - The board of directors unanimously agreed not to redeem the "Run Da Convertible Bonds" early during a meeting held on May 22, 2025, considering current market conditions and financial arrangements [6][7]. - The company will not exercise the early redemption rights for the next three months, from May 23, 2025, to August 22, 2025, even if the redemption conditions are met again [2][6]. Group 2: Convertible Bond Issuance Overview - The company issued 5,500,000 convertible bonds on June 17, 2020, with a total amount of 55 million yuan and a maturity of six years, with varying interest rates from 0.3% to 2.0% over the term [3][4]. - The initial conversion price was set at 13.36 yuan per share, which has been adjusted multiple times due to profit distributions, currently standing at 13.10 yuan per share as of July 18, 2023 [3][4]. Group 3: Related Party Transactions - The company's actual controllers, major shareholders, and senior management have not held "Run Da Convertible Bonds" in the six months prior to the redemption conditions being met and have no plans to reduce their holdings in the next six months [7].